Improving Sexual Function in Postmenopausal Women

Article

How much does ospemifene really help in the improvement of sexual function in postmenopausal women? David Portman, MD, discusses new study findings.

After menopause, some women are distressed about their inability to enjoy sex or their avoidance of intimate acts because they know it will be painful, thanks to a loss of estrogen and its effect on vulvar and vaginal tissues. Ospemifene has been approved for the treatment of dyspareunia, or painful sex, in postmenopausal women. But what kind of effect does it have on hormone levels, and how much relief does this treatment really offer?

In this video, David Portman, MD, of the Columbus Center for Women's Health Research, Columbus, Ohio, discusses what he's learned through new research on the drug and how it relates to improvement in sexual function in postmenopausal women.

This research was presented last month at the 25th Annual Meeting of The North American Menopause Society.

Recent Videos
Rossella Nappi, MD, discusses benefits of fezolinetant against vasomotor symptoms | Image Credit: imsociety.org
JoAnn Pinkerton discusses elinzanetant's crucial role in VMS therapy | Image Credit: uvahealth.com
Empowering women to take charge of their health | Image Credit: © piecesofi.com - © piecesofi.com - stock.adobe.com.
Supporting women through menopause with knowledge and care | Image Credit: © SHOTPRIME STUDIO - © SHOTPRIME STUDIO - stock.adobe.com.
How fezolinetant revolutionizes non-hormonal menopause therapy | Image Credit: imsociety.org
Gulf War exposures linked to early menopause in women veterans | Image Credit: linkedin.com.
Vanessa Muñiz discusses benefits of clinical hypnosis against hot flashes | Image Credit: mindbodymedicine.artsandsciences.baylor.edu
Related Content
© 2024 MJH Life Sciences

All rights reserved.